Inventor · disambiguated record
Donna Gutterman
Also filed as: GUTTERMAN DONNA · GUTTERMAN DONNA L · GUTTERMAN DONNA LEE
13 granted patents·25 pending applications·107 citations·filing 2000–2025
93Inventor score
Top patents by PatentIndex Score
38 records- 0195US11458110B2Treatment of Fragile X Syndrome with cannabidiolZYNERBA PHARMACEUTICALS INC·Filed 2020·Granted Oct 4, 2022·4 cites·7 claims
- 0295US10758497B2Treatment of fragile x syndrome with cannabidiolZYNERBA PHARMACEUTICALS INC·Filed 2019·Granted Sep 1, 2020·14 cites·7 claims
- 0394US11779549B2Treatment of Fragile X Syndrome with cannabidiolZYNERBA PHARMACEUTICALS INC·Filed 2022·Granted Oct 10, 2023·2 cites·2 claims
- 0494US10568848B2Treatment of autism with cannabidiolZYNERBA PHARMACEUTICALS INC·Filed 2019·Granted Feb 25, 2020·13 cites·8 claims
- 0594US10471022B2Treatment of fragile X syndrome with cannabidiolZYNERBA PHARMACEUTICALS INC·Filed 2019·Granted Nov 12, 2019·14 cites·6 claims
- 0694US10314792B2Treatment of autism with cannabidiolZYNERBA PHARMACEUTICALS INC·Filed 2018·Granted Jun 11, 2019·13 cites·7 claims
- 0794US10213390B1Treatment of fragile X syndrome with cannabidiolZYNERBA PHARMACEUTICALS INC·Filed 2018·Granted Feb 26, 2019·19 cites·8 claims
- 0893US11458109B2Treatment of 22Q11.2 deletion syndrome with cannabidiolZYNERBA PHARMACEUTICALS INC·Filed 2019·Granted Oct 4, 2022·7 cites·15 claims
- 0992US12226373B2Treatment of fragile X syndrome with cannabidiolHARMONY BIOSCIENCES MAN INC·Filed 2023·Granted Feb 18, 2025·1 cites·8 claims
- 1092US12213951B2Treatment of autism with cannabidiolHARMONY BIOSCIENCES MAN INC·Filed 2023·Granted Feb 4, 2025·1 cites·8 claims
- 1190US12186282B2Treatment of 22Q11.2 deletion syndrome with cannabidiolHARMONY BIOSCIENCES MAN INC·Filed 2022·Granted Jan 7, 2025·1 cites·20 claims
- 1282US2025213465A1Synthetic transdermal cannabidiol for the treatment of focal epilepsy in adultsZYNERBA PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1382US2025339450A1Treatment of syngap1 encephalopathyHARMONY BIOSCIENCES MAN INC·Filed 2025·Application pending·0 cites
- 1479US2022096396A1Treatment of autism with cannabidiolZYNERBA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1579US2025205174A1Treatment of 22q11.2 deletion syndrome with cannabidiolHARMONY BIOSCIENCES MAN INC·Filed 2024·Application pending·0 cites
- 1677US12508270B2Treatment of behavioral impairment in developmental and epileptic encephalopathyHARMONY BIOSCIENCES MAN INC·Filed 2022·Granted Dec 30, 2025·0 cites·14 claims
- 1777US7189753B1Preemptive prophylaxis of migraineCADY ROGER K·Filed 2000·Granted Mar 13, 2007·18 cites·9 claims
- 1877US2024148669A1Methods of treatment of osteoarthritis with transdermal cannabidiol gelZYNERBA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1976US2024189255A1Methods of treatment of osteoarthritis with transdermal cannabidiol gelZYNERBA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2074US2025134832A1Treatment of autism with cannabidiolHARMONY BIOSCIENCES MAN INC·Filed 2025·Application pending·0 cites
- 2174US2025134833A1Treatment of fragile x syndrome with cannabidiolHARMONY BIOSCIENCES MAN INC·Filed 2025·Application pending·0 cites
- 2274US2025195451A1Treatment of syngap1 encephalopathyHARMONY BIOSCIENCES MAN INC·Filed 2025·Application pending·0 cites
- 2373US2025288539A1Treatment of fragile x syndrome and autism spectrum disorder with cannabidiolHARMONY BIOSCIENCES MAN INC·Filed 2025·Application pending·0 cites
- 2472US2020214995A1Treatment of autism with cannabidiolZYNERBA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2569US2021077421A1Treatment of syngap1 encephalopathyZYNERBA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2669US2025302734A1Synthetic transdermal cannabidiol for the treatment of focal epilepsy in adultsHARMONY BIOSCIENCES MAN INC·Filed 2025·Application pending·0 cites
- 2767US2019083388A1Synthentic transdermal cannabidiol for the treatment of focal epilepsy in adultsZYNERBA PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2866US2021030665A1Synthetic transdermal cannabidiol for the treatment of focal epilepsy in adultsZYNERBA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2965US2021369643A1Treatment of fragile x syndrome and autism spectrum disorder with cannabidiolZYNERBA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3064US2025268843A1Methods of treatment of osteoarthritis with transdermal cannabidiol gelHARMONY BIOSCIENCES MAN INC·Filed 2025·Application pending·0 cites
- 3160US2023000792A1Treatment of 22q11.2 deletion syndrome with cannabidiolZYNERBA PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3260US2020170963A1Methods of treatment of osteoarthritis with transdermal cannabidiol gelZYNERBA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3358US2023000793A1Treatment of 22q11.2 deletion syndrome with cannabidiolZYNERBA PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3457US2024307418A1Treatment of sleep apnea with cbdZYNERBA PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3556US2024009210A1Cannabidiol for the Treatment of Refractory SeizuresZYNERBA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3649US2003018031A1Formulations of 5HT agonistsFiled 2002·Application pending·0 cites
- 3746US2025177322A1Treatment of fragile x syndrome with cannabidiolHARMONY BIOSCIENCES MAN INC·Filed 2025·Application pending·0 cites
- 3841US2007088006A1Preemptive Prophylaxis of MigraineCADY ROGER K·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Donna Gutterman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →